• SENSEX 81,337.95
    446.93 (+0.55%)
  • BANKNIFTY 56,222.00
    137.10 (+0.24%)
  • Larsen & Toubro
    3,504.00 3,963.00(%)
  • Vimta Labs
    722.10 722.10(%)
  • HDFC Bank
    2,027.05 2,035.00(%)
  • Waaree Energies
    3,291.95 3,740.75(%)
  • Paradeep Phosph.
    234.05 234.05(%)
  • Reliance Industr
    1,420.95 1,551.00(%)
  • ICICI Bank
    1,475.15 1,153.30(%)
  • Jayaswal Neco
    49.62 55.34(%)
  • Bajaj Finance
    893.85 978.59(%)
  • Mazagon Dock
    2,644.90 1,917.95(%)
  • Kajaria Ceramics
    1,120.65 745.00(%)
  • Bharti Airtel
    1,924.00 2,045.50(%)
  • Bharat Electron
    378.25 240.15(%)
  • Coforge
    1,692.90 1,120.01(%)
  • Amber Enterp.
    8,006.80 8,167.10(%)
  • Hind.Aeronautics
    4,401.00 3,045.95(%)
  • Suzlon Energy
    62.65 86.04(%)
  • Tata Chemicals
    1,005.30 1,244.70(%)
  • Infosys
    1,496.60 1,307.10(%)
  • Yash Highvoltage
    573.00 617.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Albert David Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 1254.0
  • ISIN : INE155C01010
907.45 17 (1.91%)
  • As on 30 Jul 2025 (EOD)
  • Today’s Low

    884.45
  • Today’s High

    913.45
  • Open

    884.45
  • Perv Close

    890.40
  • 52W Low

    762.60
  • 52W High

    1,753.95

Key Indicators

  • P/E(TTM)

    30.66

  • Mar.Cap (₹Cr.)

    518.15

  • Div & Yield %

    0.55

  • Book Value(₹)

    687.37

  • Debt-Equity Ratio

    1.91

  • AGM Date

    29-Jul-2025

  • EPS

    29.81

  • P/E Ratio

    30.66

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    518.15

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.71

  • BV (₹)

    687.40

  • Sales( ₹ in Cr.)

    345.77

  • NP (in Cr.)

    17.02

  • NP Var(%)

    -77.0

  • Div%

    50.0

  • CPS (₹)

    42.00

  • EPS (₹)

    29.80

  • Traded Value (₹ in Lakhs)

    521.84

  • 52 Week High

    1,753.95

  • 52 Week Low

    762.60

  • Price BSE

    914.0

  • Price NSE

    907.00

  • Market Capital( in Cr.)

    521.84

  • P/C Ratio

    21.80

  • P/E Ratio

    30.70

  • Price Vs.BV

    29.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 345.77 362.46 341.56 313.51 247.45 320.80
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 345.77 362.46 341.56 313.51 247.45 320.80
Other Income 29.58 57.55 15.40 15.84 17.18 7.11
Stock Adjustments 14.33 1.77 4.60 -2.38 -3.30 3.03
Total Income 389.68 421.78 361.56 326.97 261.33 330.94
EXPENDITURE :            
Raw Materials 130.61 128.17 128.67 112.56 82.87 108.42
Power and Fuel Cost 15.17 16.42 18.85 13.22 8.52 13.83
Employee Cost 109.02 88.43 81.07 85.38 82.70 90.34
Other Manufacturing Expenses 9.45 8.04 7.17 7.14 6.68 7.56
Selling and Administration Expenses 73.86 63.45 55.69 44.15 37.09 59.68
Miscellaneous Expenses 18.82 12.74 10.25 7.75 7.01 13.48
Employee Benefit Expenses 109.02 88.43 81.07 85.38 82.70 90.34
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 356.93 317.24 301.69 270.20 224.87 293.32
Operating Profit 32.75 104.54 59.86 56.77 36.46 37.61
Interest 0.55 0.43 0.58 0.67 0.78 0.98
Gross Profit 32.20 104.11 59.28 56.10 35.68 36.63
Depreciation 6.97 6.83 8.55 8.81 8.23 7.67
Profit Before Tax 25.23 97.28 50.73 47.29 27.45 28.96
Current Tax 5.92 17.59 15.96 12.61 4.37 10.60
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.10 4.28 -1.40 -0.57 0.93 -0.81
Reported Net Profit 17.20 75.42 36.17 35.26 22.14 19.17
Extraordinary Items 0.18 0.00 0.01 1.72 0.75 0.22
Adjusted Net Profit 17.02 75.42 36.16 33.54 21.39 18.95
Adjustment below Net Profit -0.31 2.96 0.65 0.55 -0.25 -4.70
P & L Balance brought forward 238.77 165.53 133.84 101.46 79.57 69.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.56 5.14 5.14 3.42 0.00 4.82
P & L Balance carried down 249.09 238.77 165.53 133.84 101.46 79.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 115.00 90.00 90.00 60.00 70.00
Dividend Per Share(Rs) 5.00 11.50 9.00 9.00 6.00 7.00
Earnings Per Share-Unit Curr 30.14 132.15 63.38 61.78 38.80 33.59
Earnings Per Share(Adj)-Unit Curr 30.14 132.15 63.38 61.78 38.80 33.59
Book Value 687.70 671.05 545.93 489.68 428.20 390.38
Book Value(Adj)-Unit Curr 687.70 671.05 545.93 489.68 428.20 390.38

Shareholding Pattern

  • Promoter Group

    62.24%

  • Public Share Holding

    37.76%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,854,431 50.01 2,854,431 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 697,527 12.22 697,527 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,551,958 62.24 3,551,958 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.01 0 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 47,982 0.84 47,982 8
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 91,850 1.61 91,850 1
Mutual Funds / UTI 800 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,264 0.02 1,264 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 142,596 2.50 141,096 13
2] Non Institution
Bodies Corporate 106,206 1.86 105,881 109
Clearing Members 77,266 1.35 77,266 15
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 50,128 0.88 50,128 276
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 103,447 1.81 103,445 489
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 94,420 1.65 94,420 3
Individuals holding nominal share capital up to Rs. 1 lakh 1,492,988 26.16 1,453,546 14,144
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 250 0.00 250 1
Others 42,577 0.75 42,577 1
Sub Total 2,012,608 35.26 1,972,839 15,049
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,707,162 100.00 5,665,893 15,070

Company Background

Albert David LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Albert David Ltd
  • BSE Code : 1254.0
  • ISIN : INE155C01010
  • Incorporation Year

    1938

  • Registered Office

    D Block 3rd Flr Gillander Hous
    Netaji Subhas Road, Kolkata,
    West Bengal-700001

  • Telephone

    91-33-22302330/2262 8436/8456/

  • FAX

    91-33-22628439

  • Chairman

    A K Kothari

  • Managing Director

    U. M. Kunte

  • Company Secretary

  • Auditor

    L B Jha & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Maheshwari Datamatics Pvt Ltd
    23 RN Mukherjee Road,
    5th Floor ,
    Mumbai - Kolkata-700001

Albert David Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Albert David 913.90 375.35 345.77 30.34 6.36
Abbott India 34,736.30 6,684.73 6,409.15 52.19 44.95
Astrazeneca Phar 8,953.75 1,756.92 1,716.29 193.39 32.94
P & G Health Ltd 5,942.10 1,166.89 1,151.26 39.27 39.76
Glaxosmi. Pharma 3,144.35 3,866.05 3,723.49 57.96 58.72
Cipla 1,574.00 20,029.57 19,044.85 23.52 21.40
Amrutanjan Healt 664.95 437.58 421.23 37.82 20.84
Guj. Themis Bio. 390.35 174.19 169.82 87.13 44.82
Fermenta Biotec. 369.50 442.21 430.53 16.09 17.61
Bliss GVS Pharma 155.65 703.42 667.20 23.80 9.16
Ambalal Sarabhai 32.39 19.33 4.04 29.99 2.10